Announcing the SCID Region of Interest Test

Severe Combined Immunodeficiency (SCID) Region of Interest

November 21, 2017

Claritas Genomics is pleased to announce the Severe Combined Immunodeficiency (SCID) Region of Interest assay, which was developed in collaboration with leading experts in pediatric immunology and evaluates 59 genes related to known causes of SCID. More information on the assay can be found here.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.